| Zoledronic Acid in Children (1 -17 Years) With Severe Osteogenesis Imperfecta (NCT00131118) | Novartis Pharmaceuticals | 2004-07-01 |
| Evaluation of the Safety, Tolerability, Pharmacokinetics (PK) and Effects on Liver Iron Concentration of ICL670 Relative to Deferoxamine(DFO). (NCT01090323) | Novartis Pharmaceuticals | 2004-07-01 |
| Post-Marketing Clinical Study of Postoperative Adjuvant Therapy With Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors (GIST) (NCT00171977) | Novartis Pharmaceuticals | 2004-07-01 |
| A Study of Imatinib 400 mg Once Daily in Combination With Methotrexate in the Treatment of Rheumatoid Arthritis. (NCT00154336) | Novartis Pharmaceuticals | 2004-07-01 |
| The Use of Zoledronic Acid in Men on Androgen Deprivation Therapy for Prostate Cancer With Preexisting Osteoporosis (NCT00171639) | Novartis Pharmaceuticals | 2004-06-01 |
| Study to Evaluate the Combination of Enteric-coated Mycophenolate Sodium (EC-MPS), Basiliximab, and C2-monitored Cyclosporine in de Novo Renal Transplant Recipients at Potential High Risk of Delayed Graft Function (DGF) (NCT00154232) | Novartis Pharmaceuticals | 2004-06-01 |
| Terbinafine Compared to Griseofulvin in Children With Tinea Capitis (NCT00117767) | Novartis Pharmaceuticals | 2004-06-01 |
| Nordic Study in Cardiac and Lung Transplantation: Outcome in Relation to Cyclosporine Microemulsion C2 Levels (NCT00154193) | Novartis Pharmaceuticals | 2004-06-01 |
| Measurement of Patient Reported Outcomes in Renal Transplant Patients With and Without Gastrointestinal (GI) Symptoms (PROGIS) (NCT00150007) | Novartis Pharmaceuticals | 2004-06-01 |
| A Study of the Clinical Safety, Tolerability, and Efficacy of Zoledronic Acid Compared to an Oral Bisphosphonate (NCT00100555) | Novartis Pharmaceuticals | 2004-06-01 |
| Efficacy and Safety of Zoledronic Acid in the Prevention and Treatment of Corticosteroid Induced Osteoporosis (NCT00100620) | Novartis Pharmaceuticals | 2004-06-01 |
| Switching Osteoporosis Patients Currently on Oral Bisphosphonate to Zoledronic Acid (NCT00097812) | Novartis Pharmaceuticals | 2004-05-01 |
| Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 Diabetes (NCT00099944) | Novartis Pharmaceuticals | 2004-05-01 |
| Efficacy and Safety of FTY720 Versus Mycophenolate Mofetil (MMF, Roche Brand) in de Novo Adult Renal Transplant Recipients (NCT00239863) | Novartis Pharmaceuticals | 2004-05-01 |
| Verification Study of Ciclosporin for Atopic Dermatitis (NCT00232076) | Novartis Pharmaceuticals | 2004-05-01 |
| Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 Diabetes (NCT00099853) | Novartis Pharmaceuticals | 2004-05-01 |
| Long-term Study of Ciclosporin for Atopic Dermatitis (NCT00232063) | Novartis Pharmaceuticals | 2004-05-01 |
| Tifacogin for the Treatment of Patients With Severe Community-Acquired Pneumonia (NCT00084071) | Novartis Pharmaceuticals | 2004-05-01 |
| Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 Diabetes (NCT00099931) | Novartis Pharmaceuticals | 2004-05-01 |
| Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes (NCT00099918) | Novartis Pharmaceuticals | 2004-05-01 |
| Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 Diabetes (NCT00099892) | Novartis Pharmaceuticals | 2004-05-01 |
| Safety, Tolerability and Pharmacokinetics of QAK423A in Healthy Volunteers and Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT01197287) | Novartis Pharmaceuticals | 2004-05-01 |
| Efficacy and Safety of FTY720 in Patients Who Receive a Kidney Transplantation (NCT00098735) | Novartis Pharmaceuticals | 2004-04-01 |
| A Study to Assess SOM230 in Patients With Pituitary Cushing's Disease (NCT00088608) | Novartis Pharmaceuticals | 2004-04-01 |
| Efficacy and Safety of Zoledronic Acid for the Treatment of Osteoporosis in Men (NCT00097825) | Novartis Pharmaceuticals | 2004-04-01 |
| Non-small Cell Lung Cancer Study US75 (Z-PACT) (NCT00086268) | Novartis Pharmaceuticals | 2004-04-01 |
| Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma (NCT00079937) | Novartis Pharmaceuticals | 2004-04-01 |
| MYPROMS-ES02: Safety and Efficacy of Basiliximab, Cyclosporine Microemulsion and Enteric-coated Mycophenolate Sodium (EC-MPS) Versus EC-MPS and Steroid Therapy in Kidney Transplant Recipients Who Are Hepatitis C Positive (NCT00284921) | Novartis Pharmaceuticals | 2004-04-01 |
| A Clinical Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes (NCT00099905) | Novartis Pharmaceuticals | 2004-04-01 |
| Long Term Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients (NCT00239811) | Novartis Pharmaceuticals | 2004-04-01 |
| Pediatric Hypothalamic Obesity (NCT00076362) | Novartis Pharmaceuticals | 2004-03-01 |
| Evaluation of Efficacy of Zoledronic Acid in Patients With Haemoglobin Syndromes (Thalassemia and Sicle Cell Anaemia) and Risk of Skeletal Events (NCT00346242) | Novartis Pharmaceuticals | 2004-03-01 |
| Study Comparing SOM230 Subcutaneously and Sandostatin Subcutaneously in Acromegalic Patients (NCT00088582) | Novartis Pharmaceuticals | 2004-03-01 |
| The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer (NCT00171314) | Novartis Pharmaceuticals | 2004-03-01 |
| Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With HbA1c 9-11% (NCT00101673) | Novartis Pharmaceuticals | 2004-03-01 |
| Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment (NCT00237198) | Novartis Pharmaceuticals | 2004-03-01 |
| Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients (NCT00303329) | Novartis Pharmaceuticals | 2004-03-01 |
| PKC412, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia (NCT00093600) | Novartis Pharmaceuticals | 2004-02-01 |
| Safety and Efficacy of AAE581 in Postmenopausal Women With Osteoporosis (NCT00100607) | Novartis Pharmaceuticals | 2004-02-01 |
| Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors (NCT00088595) | Novartis Pharmaceuticals | 2004-01-01 |
| A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril (NCT00171119) | Novartis Pharmaceuticals | 2004-01-01 |
| Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes (NCT00099866) | Novartis Pharmaceuticals | 2004-01-01 |
| Study of AEE788 in Patients With Recurrent/Relapse Glioblastoma Multiforme (GBM) (NCT00116376) | Novartis Pharmaceuticals | 2004-01-01 |
| A Study to Evaluate the Efficacy and Tolerability of Zoledronic Acid in Patients With Metastatic Prostate Cancer Who Can be Treated With a Group of Medications Known as Bisphosphonates (NCT00172016) | Novartis Pharmaceuticals | 2004-01-01 |
| Study Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer (NCT00073528) | Novartis Pharmaceuticals | 2003-12-09 |
| A Prostate Cancer Study in Men Undergoing Androgen Deprivation Therapy (NCT00087659) | Novartis Pharmaceuticals | 2003-12-01 |
| Safety of CHIR-258 (TKI258) in Advanced Solid Tumors (NCT01270906) | Novartis Pharmaceuticals | 2003-12-01 |
| Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis (NCT00076336) | Novartis Pharmaceuticals | 2003-12-01 |
| Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease (NCT00099242) | Novartis Pharmaceuticals | 2003-11-01 |
| Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant (NCT00099749) | Novartis Pharmaceuticals | 2003-11-01 |
| Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone Orchiectomy (NCT00237146) | Novartis Pharmaceuticals | 2003-11-01 |
| Safety, Tolerability and Efficacy of Everolimus With Lower Versus Higher Levels of Tacrolimus in de Novo Renal Transplant Patients (NCT00170833) | Novartis Pharmaceuticals | 2003-11-01 |
| Dose-Escalation Study in Advanced Colon Cancer Patients (NCT00969046) | Novartis Pharmaceuticals | 2003-11-01 |
| Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification (NCT00124709) | Novartis Pharmaceuticals | 2003-10-01 |
| Gleevec Trial in Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (NCT00081926) | Novartis Pharmaceuticals | 2003-10-01 |
| AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme (NCT00107237) | Novartis Pharmaceuticals | 2003-10-01 |
| Efficacy Study of Imatinib Mesylate to Treat Philadelphia-Positive Acute Lymphocytic Leukemia (NCT00154349) | Novartis Pharmaceuticals | 2003-10-01 |
| Assessment of the Efficacy, Tolerability and Pharmaco-economic Impact of Zoledronic Acid Treatment in Prostate Cancer With Bone Metastasis (NCT00241111) | Novartis Pharmaceuticals | 2003-09-01 |
| Study Evaluating TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis (ALS) (NCT00072709) | Novartis Pharmaceuticals | 2003-09-01 |
| A 4-year Extension Study to Core 1-year Study of Iron Chelation Therapy With Deferasirox in β-thalassemia Major Pediatric Patients With Transfusional Iron Overload. (NCT00390858) | Novartis Pharmaceuticals | 2003-09-01 |
| Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate Cancer (NCT00219271) | Novartis Pharmaceuticals | 2003-09-01 |
| A Clinical Study to Assess the Effect of Vildagliptin on Postprandial Lipid Parameters in Patients With Type 2 Diabetes (NCT00099957) | Novartis Pharmaceuticals | 2003-09-01 |
| Dose Escalating Study of the Safety and Efficacy of Patupilone, q3w, in Patients With Non-small Cell Lung Cancer (NCT00171834) | Novartis Pharmaceuticals | 2003-08-01 |
| Study of Oral AEE788 in Adults With Advanced Cancer (NCT00118456) | Novartis Pharmaceuticals | 2003-07-01 |
| Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy (NCT01316458) | Novartis Pharmaceuticals | 2003-06-01 |
| Bisphosphonate Treatment of Osteogenesis Imperfecta (NCT00063479) | Novartis Pharmaceuticals | 2003-06-01 |
| A Protocol to Allow Treatment With ICL670 for Patients With or at Risk of Life-threatening Complications of Transfusional Iron Overload Who Are Unable to Tolerate Other Iron Chelators Because of Documented Severe Toxicity (NCT01044186) | Novartis Pharmaceuticals | 2003-06-01 |
| Efficacy and Safety of FTY720 in Patients Who Receive a Kidney Transplant (NCT00099736) | Novartis Pharmaceuticals | 2003-05-07 |
| Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood Transfusions (NCT00067080) | Novartis Pharmaceuticals | 2003-05-01 |
| Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias (NCT00061763) | Novartis Pharmaceuticals | 2003-05-01 |
| Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood Transfusions (NCT00061750) | Novartis Pharmaceuticals | 2003-05-01 |
| A Pilot Study to Evaluate the Effects of Nateglinide vs. Glibenclamide on Renal Hemodynamics and Albumin Excretion (NCT00238472) | Novartis Pharmaceuticals | 2003-05-01 |
| Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer. (NCT00171340) | Novartis Pharmaceuticals | 2003-05-01 |
| Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients (NCT00239785) | Novartis Pharmaceuticals | 2003-04-01 |
| Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Heart Transplant Recipients (NCT00238446) | Novartis Pharmaceuticals | 2003-04-01 |
| The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy (NCT00063609) | Novartis Pharmaceuticals | 2003-04-01 |
| Treatment of Locally Advanced Breast Cancer With Letrozole in Postmenopausal Women (NCT00237133) | Novartis Pharmaceuticals | 2003-03-01 |
| Freedom Study: Myfortic in Kidney Transplant Patients (NCT00101738) | Novartis Pharmaceuticals | 2003-03-01 |
| Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer (NCT00171847) | Novartis Pharmaceuticals | 2003-03-01 |
| A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies (NCT00621244) | Novartis Pharmaceuticals | 2003-03-01 |
| Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With Acromegaly, With Micro or Macroadenomas (NCT00242541) | Novartis Pharmaceuticals | 2003-03-01 |
| Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584 (NCT00052013) | Novartis Pharmaceuticals | 2003-02-01 |
| Safety and Efficacy of Deferasirox in Patients With Transfusion Dependent Iron Overload - a Non-comparative Extension Study (NCT01033747) | Novartis Pharmaceuticals | 2003-02-01 |
| Open Label Study of Postmenopausal Women With ER and /or PgR Positive Breast Cancer Treated With Letrozole (NCT00237224) | Novartis Pharmaceuticals | 2003-02-01 |
| A Study to Investigate the Tolerability and Safety of Converting Stable Renal Transplant Recipients Who Receive Tacrolimus With or Without Corticosteroids From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS) (NCT00238979) | Novartis Pharmaceuticals | 2003-01-01 |
| Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer (NCT00056446) | Novartis Pharmaceuticals | 2003-01-01 |
| An Open Label Study to Evaluate the Tolerability and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion (CsA-ME) in Maintenance Renal Transplant Recipients (NCT00239044) | Novartis Pharmaceuticals | 2002-12-01 |
| Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Steroid Withdrawal vs EC-MPS With Standard Steroid Regimen in de Novo Renal Transplant Recipients. (NCT00238992) | Novartis Pharmaceuticals | 2002-12-01 |
| Cyclosporine A C-2h Monitoring Versus Tacrolimus C-0h Monitoring in de Novo Liver Transplant Recipients (NCT00149994) | Novartis Pharmaceuticals | 2002-12-01 |
| STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea (NCT00050635) | Novartis Pharmaceuticals | 2002-12-01 |
| Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal Tumors (NCT01275222) | Novartis Pharmaceuticals | 2002-11-13 |
| Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs. Surgery in Treatment-naïve Patients With Acromegaly (NCT00225979) | Novartis Pharmaceuticals | 2002-11-01 |
| Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastases (NCT00242554) | Novartis Pharmaceuticals | 2002-10-01 |
| Letrozole in the Treatment of Severe and Recurrent Endometriosis (NCT00240942) | Novartis Pharmaceuticals | 2002-10-01 |
| Effect of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastasis (NCT00237159) | Novartis Pharmaceuticals | 2002-10-01 |
| Phase II Clinical Study of Imatinib Mesylate in Patients With Malignant Gastrointestinal Stromal Tumors (Extension Study) (NCT00237172) | Novartis Pharmaceuticals | 2002-09-01 |
| Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy (NCT00050011) | Novartis Pharmaceuticals | 2002-09-01 |
| A Study to Determine the Safety and Efficacy of Imatinib Mesylate in Patients With Idiopathic Hypereosinophilic Syndrome (NCT00171860) | Novartis Pharmaceuticals | 2002-09-01 |
| EPO906 in Carcinoid and Other Neuroendocrine Tumors (NCT00050349) | Novartis Pharmaceuticals | 2002-07-01 |
| Pediatric Epilepsy Study (NCT00050947) | Novartis Pharmaceuticals | 2002-07-01 |